Buspirone Hydrochloride
- Product NDC
- 51655-796
- 11-digit product format
- 516550796
- Labeler code
- 51655
- Product ID
- 51655-796_4ba8aa52-6d36-c075-e063-6294a90a25a0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Buspirone Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northwind Health Company, LLC
- Application
- ANDA202330
- Marketing category
- ANDA
- Marketing start
- 2022-02-18
- Substance
- BUSPIRONE HYDROCHLORIDE
- Active strength
- 10 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Buspirone Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BUSPIRONE HYDROCHLORIDE | 10 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 207LT9J9OC |
| Rxcui | 866083 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51655-796-26 | Buspirone Hydrochloride | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51655-796 | BUSPIRONE HYDROCHLORIDE TABLET [NORTHWIND PHARMACEUTICALS] | 2 | Current NDC, Legacy NDC, 1 package rows | 20231219_d9de7cf1-c38d-8b3c-e053-2995a90aa26b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51655-796-26 | 51655079626 | 90 TABLET in 1 BOTTLE, PLASTIC (51655-796-26) | 90 tablet | 2022-02-18 | 0000-00-00 | No | No | Current |